Role of 14-3-3ε, c-Myc/Max, and Akt phosphorylation in HIV-1 gp 120-induced mesangial cell proliferation

American Journal of Physiology - Renal Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Kapasi, Aditi A ^a   Fan, Saijun ^a   Singhal, Pravin C ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

ATP dependent tyrosine kinases; Human immunodeficiency virus 1 glycoprotein 120; Human mesangial cells; Max; Myc; Proliferation

Indexed keywords

FAS LIGAND; GLYCOPROTEIN GP 120; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME PHOSPHORYLATION; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; MESANGIUM CELL; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0035010931     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.280.2.f333     Document Type: Article

References (69)

1. Aitken A. 14-3-3 Proteins on the MAP. Trends Biochem Sci 20: 95-97, 1995.
2. Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995.
3. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, and Land HT. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72: 233-245, 1993.
4. Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, and Land HT. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359: 423-426, 1992.
5. Amati B and Land H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev 4: 102-108, 1994.
6. Arthos J, Deen KC, Chaikin MA, Fornwald JA, Sathe G, Sattentau QJ, Clapham PR, Weiss RA, McDougal JS, Pietropaolo C, Axel R, Truneh A, Maddon PJ, and Sweet RW. Identification of the residues in human CD4 critical for the binding of HIV. Cell 57: 469-481, 1997.
7. Basu A and Haldar S. The relationship between Bcl-2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 4: 1099-1109, 1998.
8. Billaud M, Isselbacher K, and Bernards R. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins. Proc Natl Acad Sci USA 90: 2739-2743, 1993.
9. Blackwood EM and Eisenman RN. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211-1217, 1991.
10. Blumenthal R and Dimitrov DS. Membrane fusion. In: Handbook of Physiology. Cell Physiology. Bethesda, MD: Am Physiol Soc, 1997, sect. 14, chapt. 14, p. 563-604.
11. Borchers C and Tomer KB. Characterization of the noncovalent complex of human immunodeficiency virus glycoprotein 120 with its cellular receptor CD4 by matrix-assisted laser desorption/ionization mass spectrometry. Biochemistry 38: 11734-11740, 1999.
12. Boulton TG, Gregory JS, and Cobb MH. Purification and properties of ERK 1, an insulin-stimulated MAP2 protein kinase. Biochemistry 30: 278-286, 1991.
13. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, Depinho RA, Panayotatos N, Cobb MH, and Yancopoulos GD. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663-675, 1991.
14. Bourgoignie JJ. Renal complication of human immunodeficiency virus type 1. Kidney Int 37: 1571-1584, 1990.
15. Bousset K, Henriksson M, and Eisenman RN. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers. Oncogene 8: 3211-3220, 1993.
16. Burgering BT and Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602, 1995.
17. Callebaut C, Krust B, Jcotot E, and Hovanessian AG. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD+ cells. Science 262: 2045-2050, 1993.
18. Capon DJ and Ward RH. The CD4-gp 120 interactions and AIDS pathogenesis. Annu Rev Immunol 9: 649-678, 1991.
19. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, and Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762, 1994.
20. Chirmule N, Goonewardane H, Pasieka R, Kalyanraman VS, and Pahwa S. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells. J Biol Chem 270: 19364-19369, 1995.
21. Chirmule N, Kalyanraman VS, and Pahwa S. Signal transduced through the CD4 molecule on T lymphocytes activates NF-κB. Biochem Biophys Res Commun 203: 498-504, 1994.
22. Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen LC, Boccellino M, Orlandi V, Serra C, Camussi G, and Toniolo A. HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest 102: 2041-2049, 1998.
23. Cowley S, Paterson H, Kemp P, and Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852, 1994.
24. Depinho RA, Schreiber-Agus N, and Alt FW. Myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57: 1-46, 1991.
25. Dickie P, Felser J, Echhaus M, Bryant J, Silver J, Marinos N, and Notkins AL. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185: 109-119, 1991.
26. Evans GI and Littlewood TD. The role of c-myc in cell growth. Curr Opin Genet Dev 4: 44-49, 1993.
27. Franke TF. The protein kinase encoded by the Akt protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995.
28. Franke TF. PI3K: downstream AKT-ion blocks apoptosis. Cell 88: 435-437, 1997.
29. Green DF, Resnick L, and Bourgoignie JJ. HIV infects glomerular endothelial and mesangial but not epithelial cells in vivo. Kidney Int 41: 956-960, 1992.
30. Gupta S, Seth A, and Davis RJ. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc Natl Acad Sci USA 90: 3216-3220, 1993.
31. Habeshaw JA, Dalgleish AG, Bountiff L, Newell AL, Wilks D, Walker IC, and Manca F. AIDS pathogenesis: HIV envelope and its interaction with cell proteins. Immunol Today 11: 418-425, 1990.
32. Haycock JW, Ahn NG, Cobb MH, and Kreb EG. ERK 1 and ERK 2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc Natl Acad Sci USA 89: 2365-2369, 1992.
33. Hill CS and Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80: 199-211, 1995.
34. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126, 1995.
35. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80: 225-236, 1995.
36. Kapasi AA, Fan S, and Singhal PC. HIV-1 GP 120 protein-induced mesangial cell proliferation is associated with expression of c-Myc, 14-3-3 epsilon protein and phosphorylation of Akt and ERK1/2 (Abstract). J Am Soc Nephrol 10: 495A, 1999.
37. Kapasi AA, Franki N, Ding G, and Singhal PC. Human glomerular epithelial cells express CD4 and interaction with gp 120 protein promotes PYK2 tyrosine phosphorylation. Mol Cell Biol Res Commun 1: 140-143, 1999.
38. 2 C-Jun-terminal kinase (JNK)/p38 MAPK and NF-κB in renal tubular cells (Abstract). J Am Soc Nephrol 10: 592A, 1999.
39. Kapasi AA and Singhal PC. Human renal tubular epithelial cells (HRTEC) express CD4 receptors (Abstract). J Am Soc Nephrol 9: 459A, 1998.
40. Karlsson-Parra A, Dikeny E, Fellstrom B, and Klareskog L. HIV receptors (CD4 antigen) in normal human glomerular cells. N Engl J Med 320: 741-748, 1989.
41. Kennedy SG. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11: 701-713, 1997.
42. Kimmel PL, Ferreira-Centeno A, Frank-Szallasi T, Abraham AA, and Gattey CT. Viral DNA in microdissected renal biopsy tissue from HIV-infected patients with nephrotic syndrome. Kidney Int 43: 1347-1354, 1993.
43. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Eckhaus M, Dickie P, Marinos NJ, Bryant JL, Notkins AL, and Klotman PE. Progressive glomerulosclerosis and enhanced basement membrane components in mice transgenic for HIV-1 genes. Proc Natl Acad Sci USA 89: 1577-1581, 1992.
44. Kretzner L, Blackwood EM, and Eisenman RN. Myc and Max proteins possess distinct transcriptional activities. Nature 359: 426-429, 1992.
45. Lifson JD, Feinberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, and Engleman EG. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 323: 725-728, 1986.
46. Liu YC, Elly C, Yoshida H, Bonnefoy-Berard N, and Altman A. Activation-modulated association of 14-3-3 proteins with Cbl in T cells. J Biol Chem 271: 14591-14595, 1996.
47. Luk SCW, Nagi S, Tsui SKW, Fung K, Lee C, and Waye MMY. In vivo and in vitro association of 14-3-3 epsilon isoform with calmodulin: implication for signal transduction and cell proliferation. J Cell Biochem 73: 31-35, 1999.
48. Maddon PJ, Dalgleish AG, Macdougal JS, Clapham PR, Weiss RA, and Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47: 333-348, 1986.
49. Mansour SJ, Matten WT, Hermann AS, Candida JM, Rong S, Fukasawa K, Vande W, Poud GF, and Ahn NG. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970, 1994.
50. Marcu KB, Bossone SA, and Patel AJ. Myc function and regulation. Annu Rev Biochem 61: 809-860, 1992.
51. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.
52. Mattana J, Abramovici M, and Singhal PC. Effects of HIV-1 sera and macrophage supernatants on mesangial cell proliferation and matrix synthesis. Am J Pathol 143: 814-822, 1993.
53. Morrison D. 14-3-3: Modulators of signaling proteins? Science 266: 56-57, 1994.
54. Ortiz-Arduan A, Danoff TM, Kalluri R, Gonzalez-Cuadrado S, Karp SL, Elkon K, Egido J, and Neilson EG. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1193-F1201, 1996.
55. Packham G, Porter CW, and Cleveland JL. C-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 13: 461-469, 1996.
56. Payne DM, Rossomando AJ, Martino P, Erikson AK, Her JH, Shabanowitz J, Hunt DF, Weber MJ, and Sturgill TW. Identification of the regulatory phosphorylation sites in pp42/ mitogen-activated protein kinase (MAP kinase). EMBO J 10: 885-892, 1991.
57. Pinching AJ and Nye KE. Defective signal transduction: a common pathway for cellular dysfunction in HIV infection? Immunol Today 11: 256-259, 1991.
58. Pincus SH, Messer PI Nara KG, Blattner WA, Colclough G, and Reitz M. Temporal analysis of the antibody response to HIV envelope protein in HIV infected laboratory workers. J Clin Invest 93: 2505-2513, 1994.
59. Posner MR, Cavacini LA, Emes CL, Power J, and Byrn R. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp 120. J Acquired Immune Defic Syndr 6: 7-14, 1993.
60. Prendergast GC, Lawe D, and Ziff EB. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65: 395-407, 1991.
61. Rao TK, Fillipone EJ, and Nicastri AD. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669-673, 1984.
62. Sale EM, Atkinson PG, and Sale GJ. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation DNA synthesis. EMBO J 14: 674-684, 1994.
63. Singhal PC, Sagar S, Chandra D, and Garg P. HIV-1 gp 120 and gp 160 envelope proteins modulate mesangial cell gelatinolytic activity. Am J Pathol 147: 25-32, 1995.
64. Singhal PC, Sagar S, Reddy K, Sharma P, Ranjan R, and Franki N. HIV-1 gp120 envelope protein and morphine-tubular cell interaction products modulate kidney fibroblast proliferation. J Invest Med 46: 243-248, 1998.
65. Singhal PC, Sharma P, Kapasi AA, Reddy K, Franki N, and Gibbons N. Morphine enhances macrophage apoptosis. J Immunol 160: 1886-1893, 1998.
66. Singhal PC, Sharma P, Reddy K, Sanwal V, Rawal J, Gibbons N, and Franki N. HIV-1 gp 160 envelope glycoprotein modulates proliferation and apoptosis in mesangial cells. Nephron 76: 284-295, 1997.
67. Sodroski J, Goh WC, Rosen C, Campbell K, and Haseltine A. Role of HTLV-III/LAV envelop in syntium formation and cytopathy. Nature (Lond) 332: 470-474,1986.
68. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122, 1995.
69. Zhang H, Fan S, and Prochownik EV. Distinct roles for Max protein isoforms in proliferation and apoptosis. J Biol Chem 272: 17416-17424, 1997.